Evaluation of the Effectiveness of a Novel Brain-Computer Interface Neuromodulative Intervention to Relieve Neuropathic Pain Following Spinal Cord Injury: Protocol for a Single-Case Experimental Design With Multiple Baselines (Preprint)

Negin Hesam‐Shariati, Toby Newton‐John, Avinash Kumar Singh, Carlos Cortes, Thomas Do, Ashley Craig, James Middleton, Mark P. Jensen, Zina Trost, Chin‐Teng Lin, Sylvia M. Gustin2020 · DOI

TL;DR

This paper outlines a novel brain-computer interface (BCI) intervention designed to alleviate neuropathic pain in individuals with spinal cord injury (SCI). By leveraging an interactive gaming environment and targeted EEG neurofeedback, the study aims to provide a more engaging and potentially effective treatment for a condition that is often resistant to conventional therapies.

What Problem Does This Paper Address?

Neuropathic pain is a significant and debilitating issue for approximately 50% of individuals with spinal cord injury (SCI). This type of pain is notoriously difficult to treat, with existing pharmacological and non-pharmacological interventions offering limited relief and often carrying substantial side effects. The underlying mechanisms are complex, but research points to disruptions in thalamocortical rhythms, characterized by altered brainwave activity (specifically, increased theta and high beta, and decreased alpha frequencies). While BCI systems have shown promise in modulating these rhythms and reducing pain, current interventions often lack engagement, relying on simple visual feedback. This study seeks to address this gap by developing and testing a more immersive BCI intervention within a gaming context.

Methods

The core of this research is a novel brain-computer interface (BCI)-based neuromodulative intervention. The intervention utilizes an interactive gaming interface, dubbed "NeuroGame," and a specific neuromodulation protocol. This protocol aims to suppress theta (4-8 Hz) and high beta (20-30 Hz) frequency powers in EEG signals while simultaneously enhancing alpha (9-12 Hz) power. This targeted modulation is designed to restore more typical thalamocortical rhythms.

The study employs a single-case experimental design (SCED) with multiple baselines across participants. This design is chosen because it's well-suited for evaluating interventions in populations where recruiting large sample sizes is challenging. Three participants with SCI-induced neuropathic pain will be recruited. Each participant will be randomly assigned to a different baseline phase duration (7, 10, or 14 days). Following their respective baseline periods, participants will undergo 20 sessions of the 30-minute BCI-N intervention over a 4-week period.

Datasets

Not discussed in the paper.

Key Insights and Ideas

  • Gaming for Pain Relief: The integration of a BCI intervention within a goal-directed gaming environment is a key innovation. The hypothesis is that this immersive approach will lead to greater cortical involvement and, consequently, more effective pain relief compared to simpler, non-interactive BCI feedback.
  • Targeted Neuromodulation: The specific targeting of theta, alpha, and high beta frequency bands in EEG is based on existing research linking these patterns to neuropathic pain in SCI. The intervention aims to actively "retrain" the brain's electrical activity.
  • Single-Case Experimental Design (SCED): The use of SCED with multiple baselines is a strength, allowing for rigorous within-participant analysis and demonstrating intervention effects when they occur for each individual, which is particularly valuable for heterogeneous conditions like SCI neuropathic pain.
  • Multi-faceted Assessment: Beyond pain intensity, the study also assesses pain interference, quality of life, sleep quality, anxiety, and depressive symptoms. This comprehensive approach aims to capture the broader impact of the intervention.

Key Results

As this is a protocol paper, the results of the intervention are not yet available. The paper outlines the planned methodology and expected outcomes. The study aims to evaluate the effectiveness of the BCI-N intervention in reducing average pain intensity (primary outcome) and pain interference (secondary outcome). Generalization measures will assess broader impacts on well-being.

Limitations and Future Work

The authors acknowledge that the SCED trial with multiple baselines might be compromised if any of the three participants drop out during the baseline or intervention phases. To mitigate this, they plan to conduct a mock BCI-N treatment session for each participant beforehand to enhance compliance and comfort.

Future work will involve analyzing the collected data using both visual inspection and statistical methods (specifically, nonoverlap indices like Tau-U) to determine the reliability and consistency of the intervention's effects. The insights gained from this study, including participant feedback on feasibility and safety, will be used to optimize the technological design, clinical protocols, and assessment procedures for larger future trials. The ultimate goal is to establish this BCI-N intervention as a viable evidence-based practice for managing SCI neuropathic pain.

Summary updated

Abstract

<sec> <title>BACKGROUND</title> Neuropathic pain is a debilitating secondary condition for many individuals with spinal cord injury. Spinal cord injury neuropathic pain often is poorly responsive to existing pharmacological and nonpharmacological treatments. A growing body of evidence supports the potential for brain-computer interface systems to reduce spinal cord injury neuropathic pain via electroencephalographic neurofeedback. However, further studies are needed to provide more definitive evidence regarding the effectiveness of this intervention. </sec> <sec> <title>OBJECTIVE</title> The primary objective of this study is to evaluate the effectiveness of a multiday course of a brain-computer interface neuromodulative intervention in a gaming environment to provide pain relief for individuals with neuropathic pain following spinal cord injury. </sec> <sec> <title>METHODS</title> We have developed a novel brain-computer interface-based neuromodulative intervention for spinal cord injury neuropathic pain. Our brain-computer interface neuromodulative treatment includes an interactive gaming interface, and a neuromodulation protocol targeted to suppress theta (4-8 Hz) and high beta (20-30 Hz) frequency powers, and enhance alpha (9-12 Hz) power. We will use a single-case experimental design with multiple baselines to examine the effectiveness of our self-developed brain-computer interface neuromodulative intervention for the treatment of spinal cord injury neuropathic pain. We will recruit 3 participants with spinal cord injury neuropathic pain. Each participant will be randomly allocated to a different baseline phase (ie, 7, 10, or 14 days), which will then be followed by 20 sessions of a 30-minute brain-computer interface neuromodulative intervention over a 4-week period. The visual analog scale assessing average pain intensity will serve as the primary outcome measure. We will also assess pain interference as a secondary outcome domain. Generalization measures will assess quality of life, sleep quality, and anxiety and depressive symptoms, as well as resting-state electroencephalography and thalamic γ-aminobutyric acid concentration. </sec> <sec> <title>RESULTS</title> This study was approved by the Human Research Committees of the University of New South Wales in July 2019 and the University of Technology Sydney in January 2020. We plan to begin the trial in October 2020 and expect to publish the results by the end of 2021. </sec> <sec> <title>CONCLUSIONS</title> This clinical trial using single-case experimental design methodology has been designed to evaluate the effectiveness of a novel brain-computer interface neuromodulative treatment for people with neuropathic pain after spinal cord injury. Single-case experimental designs are considered a viable alternative approach to randomized clinical trials to identify evidence-based practices in the field of technology-based health interventions when recruitment of large samples is not feasible. </sec> <sec> <title>CLINICALTRIAL</title> Australian New Zealand Clinical Trials Registry (ANZCTR) ACTRN12620000556943; https://bit.ly/2RY1jRx </sec> <sec> <title>INTERNATIONAL REGISTERED REPORT</title> PRR1-10.2196/20979 </sec>
BibTeX
@misc{hesamshariati2020evaluation,
  author = {Negin Hesam‐Shariati and Toby Newton‐John and Avinash Kumar Singh and Carlos Cortes and Thomas Do and Ashley Craig and James Middleton and Mark P. Jensen and Zina Trost and Chin‐Teng Lin and Sylvia M. Gustin},
  title = {{Evaluation of the Effectiveness of a Novel Brain-Computer Interface Neuromodulative Intervention to Relieve Neuropathic Pain Following Spinal Cord Injury: Protocol for a Single-Case Experimental Design With Multiple Baselines (Preprint)}},
  year = {2020},
  doi = {10.2196/preprints.20979},
}

Loading related content...

Figure